Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1350.00
-3.00 (-0.22%)
< Home < Back

Cipla informs about acquisition

Date: 06-01-2024
Cipla has informed that Cipla (EU), wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The above information is a part of company’s filings submitted to BSE.